Safety and Immunogenicity of an FhSAMS Vaccine Against Fasciola hepatica in Dairy Cattle
Parasite Immunology · 2024
DOI: 10.1111/pim.13074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite Immunology, 2024. Verfasst von Kelvinson Fernandes Viana und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Fo…. Hauptthemen laut MEDLINE: Fascioliasis, Fasciola hepatica, Cattle Diseases, Antigens, Helminth. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Esprito Santo Research and Support Foundation (FAPES), Araucaria Foundation, Fundação de Amparo à Pesquisa e Inovação do Espírito Santo.
Abstract (Originalsprache)
Fasciolosis is a parasitosis of great importance for livestock, as well as for public health, as it is considered by the WHO as a neglected disease. Disease control is complex and reinfections make the use of therapeutic products an unsustainable method from an economic, environmental and health point of view. The aim of this study was to evaluate a new vaccine formulation for dairy cattle, containing soluble Fasciola hepatica antigens associated with Montanide 763 AVG and saponin adjuvants (FhSAMS). The vaccine was tested with two protocols, a single dose and a booster dose 6 months after the first dose. The FhSAMS vaccine proved to be safe, with no side effects. Furthermore, it was able to generate a more robust humoral immune response when a six‐month booster dose was used, in addition to stimulating greater production of IFN‐ʏ, indicating a Th1 profile immune stimulus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu, Puerto Rico, Brazil.
- Department of Veterinary Medicine, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil.
ORCID-Profile: Kelvinson Fernandes Viana, Felipe Berbari Neto
Förderung
- Esprito Santo Research and Support Foundation (FAPES)
- Araucaria Foundation
- Fundação de Amparo à Pesquisa e Inovação do Espírito Santo
- Fundacion Araucaria
Zitieren
APA
Viana, K. F., Sperandio, N. D. C., Neto, F. B., Donatele, D. M., de Souza, A. B., Dos Santos, A. G. V., Rivas, A. V., Barcellos, E. C. A., & Martins, I. V. F. (2024). Safety and Immunogenicity of an FhSAMS Vaccine Against Fasciola hepatica in Dairy Cattle. Parasite Immunology. https://doi.org/10.1111/pim.13074
Vancouver
Viana KF, Sperandio NDC, Neto FB, Donatele DM, de Souza AB, Dos Santos AGV, et al. Safety and Immunogenicity of an FhSAMS Vaccine Against Fasciola hepatica in Dairy Cattle. Parasite Immunology. 2024. doi:10.1111/pim.13074
BibTeX
@article{Viana2024,
author = {Viana, Kelvinson Fernandes and Sperandio, Natânia do Carmo and Neto, Felipe Berbari and Donatele, Dirlei Molinari and de Souza, Adrieli Barboza and Dos Santos, Angelo Gabriel Vidal and Rivas, Açucena Veleh and Barcellos, Ema Carolina de Almeida and Martins, Isabella Vilhena Freire},
title = {Safety and Immunogenicity of an FhSAMS Vaccine Against Fasciola hepatica in Dairy Cattle},
journal = {Parasite Immunology},
year = {2024},
doi = {10.1111/pim.13074}
}
EUVIMED